Stem Point Capital LP Amicus Therapeutics, Inc. Transaction History
Stem Point Capital LP
- $334 Billion
- Q3 2024
A detailed history of Stem Point Capital LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 1,481,809 shares of FOLD stock, worth $14.5 Million. This represents 4.74% of its overall portfolio holdings.
Number of Shares
1,481,809
Previous 1,495,047
0.89%
Holding current value
$14.5 Million
Previous $14.8 Billion
6.71%
% of portfolio
4.74%
Previous 4.36%
Shares
4 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$282 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$275 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$239 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$235 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$227 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.75B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...